Rain Oncology Inc. Proceeds from Common Stock Issued
Rain Oncology Inc. reported Proceeds from Common Stock Issued of $343.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-11-09
- Rain Oncology Inc. proceeds from issuance of common stock for the quarter ending 2023-09-30 was $0.00.
- Rain Oncology Inc. proceeds from issuance of common stock for the quarter ending 2023-06-30 was $0.00.
- Rain Oncology Inc. proceeds from issuance of common stock for the quarter ending 2023-03-31 was $343.00K.
- Rain Oncology Inc. proceeds from issuance of common stock for fiscal 2022 was $56.65M.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $343.00K 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $343.00K 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | $343.00K 10-Q · filed 2023-05-11 | ||||
| 2022-12-31 | $56.65M 10-K · filed 2023-03-09 | ||||
| 2022-11-30 | $52.90M 10-K · filed 2023-03-09 |